Characteristics of the immunological response in the clearance of non- typeable Haemophilus influenzae from the lung

Immunology and Cell Biology

Volumn 76, Issue 4, 1998, Pages 323-331

  Foxwell, A Ruth ^a   Kyd, Jennelle M ^a   Cripps, Allan W ^a  

^a UNIVERSITY OF CANBERRA   (Australia)

Author keywords

Haemophilus influenzae; Lung; Macrophage; Mucosal; Non typeable; Polymorphs; Vaccine

Indexed keywords

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL COLONIZATION; HAEMOPHILUS INFLUENZAE; IMMUNE RESPONSE; LUNG CLEARANCE; LUNG INFECTION; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; RAT; RECEPTOR UPREGULATION;

ADULT; ANIMALS; ANTIBODIES, BACTERIAL; BLOOD VESSELS; BRONCHITIS; BRONCHOALVEOLAR LAVAGE FLUID; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; INFLAMMATION; LEUKOCYTES; LUNG; MALE; NEUTROPHILS; RATS; RATS, WISTAR; VACCINATION;

ANIMALIA; BACTERIA (MICROORGANISMS); HAEMOPHILUS INFLUENZAE;

EID: 0031859288     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1998.00740.x     Document Type: Article

References (51)

1. Turk DC. The pathogenicity of Haemophilus influenzae. J. Med. Microbiol. 1984; 18: 1-16.
2. Lehmann D, Coakley KJ, Croakley CA et al. Reduction in the incidence of acute bronchitis by an oral Haemophilus influenzae vaccine in patients with chronic bronchitis in the highlands of Papua New Guinea. Am. Rev. Respir. Dis. 1991; 144: 324-30.
3. Smith-Vaughan HC, Leach AJ, Shelby-James TM, Kemp K, Kemp DJ, Mathews JD. Carriage of multiple ribotypes of nonencapsulated Haemophilus influenzae in aboriginal infants with otits media. Epidemiol. Infect. 1996; 116: 177-83.
4. Murphy TF, Apicella MA. Non-typable Haemophilus influenzae: A review of clinical aspects, surface antigens, and the human immune response to infection. Rev. Infect. Dis. 1987; 9: 1-15.
5. St Gerne III JW. Non-typeable Haemophilus influenzae disease: Epidemiology, pathogenesis, and prospects for prevention. Infect. Agents Dis. 1993; 2: 1-16.
6. Groeneveld K, Eijk PP, van Alphen L, Jansen HM, Zanen HC. Haemophilus influenzae infections in patients with chronic obstructive pulmonary disease despite specific antibodies in serum and sputum. Am. J. Respir. Crit. Care Med. 1990; 141: 1316-21.
7. Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1992; 146: 1067-83.
8. Adler KB, Hendley DD, Davis GS. Bacteria associated with obstructive pulmonary disease elaborate extracellular products that stimulate mucin secretion by explants of guinea pig airways. Am. J. Pathol. 1986; 125: 501-14.
9. Read RC, Wilson R, Rutman A et al. Interaction of non-typable Haemophilus influenzae with human respiratory mucosa in vitro. J. Infect. Dis. 1991; 163: 549-58.
10. Reddy MS, Bernstein JM, Murphy TF, Faden HS. Binding between outer membrane proteins of non-typeable Haemophilus influence and human nasopharyngeal mucin. Infect. Immun. 1996; 64: 1477-9.
11. van Alphen L, Jansen HM, Dankert J. Virulence factors in the colonization and the persistence of bacteria in the airways. Am. J. Respir. Crit. Care Med. 1995; 151: 2094-100.
12. Wallace FJ, Clancy RL, Cripps AW. An animal model demonstration of enhanced clearance of non-typeable Haemophilus influenzae from the respiratory tract after antigen stimulation of gut-associated lymphoid tissue. Am. Rev. Respir. Dis. 1989; 140: 311-16.
13. Toews GB, Vial WC, Hansen EJ. Role of C5 and recruited neutrophils in early clearance of non-typable Haemophilus influenzae from murine lungs. Infect. Immun. 1985; 50: 207-12.
14. Hansen EJ, Hart DA, McGehee JL, Toews GB. Immune enhancement of pulmonary clearance of non-typable Haemophilus influenzae. infect. Immun. 1988; 56: 182-90.
15. Wilson NR, Dunkley ML, Buret A, Young B, Cripps AW. Histopathology of the lung following intra-tracheal challenge with live Pseudomonas aeruginosa in intestinally immunized rats. Immunol. Cell Biol. 1995; 73: 440-5.
16. Murphy TF, Bartos LC. Purification and analysis with monoclonal antibodies of P2, the major outer membrane protein of non-typable Haemophilus influenzae. Infect. Immun. 1988; 56: 1084-9.
17. Kyd JM, Taylor D, Cripps AW. Conservation of immune responses to proteins isolated by preparative polyacrylamide gel electrophoresis from the outer membrane of non-typeable Haemophilus influenzae. Infect. Immun. 1994; 62: 5652-8.
18. Dunkley ML, Husband AJ. Distribution and functional characteristics of antigen-specific helper T cells arising after Peyer's patch immunization. Immunology 1987; 61: 475-82.
19. Reudl C, Frühwirth M, Wick G, Wolf H. Immune response in the lungs following oral immunization with bacterial lysates of respiratory pathogens. Clin. Diagn. Lab. Immunol. 1994; 1: 150-4.
20. Musher DM, Kubitschek KR, Crennan J, Baughn RE. Pneumonia and acute febrile tracheobronchitis due to Haemophilus influenzae. Ann. Intern. Med. 1983; 99: 444-50.
21. Murphy TF, Bartos LC, Rice PA, Nelson MB, Dudas KC, Apicella MA. Identification of a 16000-dalton outer membrane protein on non-typeable Haemophilus influenzae as a target for human serum bactericidal antibody. J. Clin. Invest. 1986; 78: 1020-7.
22. Kodama H, Faden H. Cellular immunity to the P6 outer membrane protein of non-typeable Haemophilus influenzae. Infect. Immun. 1995; 63: 2467-72.
23. Yamanaka N, Faden H. Antibody response to outer membrane protein of non-typeable Haemophilus influenzae in otitis-prone children. J. Pediatr. 1993; 122: 212-18.
24. Wallace FJ, Witt CS, Clancy RL, Cripps AW. Protection against non-typable Haemophilus influenzae following sensitization of gut associated lymphoid tissue: Role of specific antibody and phagocytes. Immunol. Cell Biol. 1995; 73: 258-65.
25. Wallace FJ, Cripps AW, Clancy RL, Husband AJ, Witt CS. A role for intestinal T lymphocytes in bronchus mucosal immunity. Immunology 1991; 74: 68-73.
26. Kemp AS, Cripps AW, Brown S. Suppression of leucocyte chemokinesis and chemotaxis by human IgA. Clin. Exp. Immunol. 1980; 40: 388-95.
27. Wolf HM, Vogel E, Fischer MB, Rengs H, Schwarz H-P, Eibl MM. Inhibition of receptor-dependent and receptor-independent generation of the respiratory burst in human neutrophils and monocytes by human serum IgA. Pediatr. Res. 1994; 36: 235-43.
28. Wolf HM, Fischer MB, Puhringer H, Samatag A, Vogel E, Eibl MM. Human serum IgA downregulales the release of inflammatory cytokines (tumour necrosis factor-α. interleukin-6) in human monocytes. Blood 1994; 83: 1278-88.
29. Cundell DR, Taylor GW, Kanthakumar K et al. Inhibition of human neutrophil migration in vitro by low-molecular-mass products of non-typeable Haemophilus influenzae. Infect Immun. 1993; 61: 2419-24.
30. Vosbeck K, Tobias P, Mueller H et al. Priming of polymorphonuclear granulocytes by lipopolysaccharides and its complexes with lipopolysaccharide binding protein and high density lipoprotein. J. Leukoc. Biol. 1990; 47: 97-104.
31. Rosales C, Juliano RL. Signal transduction by cell adhesion receptors in leucocytes. J. Leukoc. Biol. 1995; 57: 189-98.
32. Carlos TM, Harlan JM. Leucocyte-endothelial adhesion molecules. Blood 1994; 84: 2068-101.
33. Springer TA. Traffic signals for lymphocyte recirculation and leucocyte emigration: The multistep paradigm. Cell 1994; 76: 301-14.
34. Henninger DD, Panes J, Eppihimer M et al. Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J. Immunol. 1997; 158: 1825-32.
35. Watson RWG, Rotstein OD, Nathens AB, Parodo J, Marshall JC. Neutrophil apoptosis is modulated by endothelial transmigration and adhesion molecule engagement. J. Immunol. 1997; 158: 945-53.
36. Tsuchida H, Takeda Y, Takei H, Shinzawa H, Takahashi T, Sendo F. In vivo regulation of rat neutrophil apoptosis occurring spontaneously or induced with TNF-α or cycloheximide. J. Immunol. 1995; 154: 2403-12.
37. Czuprynski CJ, Henson PM, Campbell PA. Enhanced accumulation of inflammatory neutrophils and macrophages mediated by transfer of T cells from mice immunized with Listeria monocytogenes J. Immunol. 1985; 134: 3449-54.
38. Zhang J-H, Ferrante A, Arrigo A-P, Dayer J-M. Neutrophil stimulation and priming by direct contact with activated human T lymphocytes. J. Immunol. 1992; 148: 177-81.
39. Cripps AW, Dunkley ML, Clancy RL, Kyd J. Vaccine stategies against Pseudomonas aeruginosa infection in the lung. Behring Ints. Mitt. 1997; 98: 262-8.
40. 2-macroglobulin. J. Immunol. 1997; 158: 1930-40.
41. Oishi K, Sonada F, Kobayashi S et al. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases. Infect. Immun. 1994; 62: 4145-52.
42. Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 1990; 141: 471-501.
43. Fischer H-G, Frosch S, Reske K, Reske-Kunz AB. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function. J. Immunol. 1988; 141: 3882-8.
44. Agostini C, Trentin L, Zambello R et al. Release of granulocyte-macrophage colony-stimulating factor by alveolar macrophages in the lung of HIV-1-infected patients. J. Immunol. 1992; 149: 3379-85.
45. Luo G, Niesel DW, Shaban RA, Grimm EA, Klimpel GR. Tumour necrosis factor alpha binding to bacteria: Evidence for a high-affinity receptor and alteration of bacterial virulence properties. Infect. Immun. 1993; 61: 830-5.
46. Nelson S, Bagby GJ, Bainton BG, Wilson LA, Thompson JJ, Summer WR. Compartmentalization of intra-alveolar and systemic lipopolysaccharide-induced tumour necrosis factor and the pulmonary inflammatory response. J. Infect. Dis. 1989; 159: 189-94.
47. Tan A-M, Ferrante A, Goh DHB, Robertson DM, Cripps AW. Activation of the neutrophil bactericidal activity for non-typable Haemophilus influenzae by tumour necrosis factor and lymphotoxin. Pediatr. Res. 1995; 37: 155-9.
48. Thepen T, McMenamin C, Oliver J, Kraal G, Holt PG. Regulation of immune response to inhaled antigen by alveolar macrophages: Differential effects of in vivo alveolar macrophage elimination on the induction of tolerance vs. immunity. Eur. J. Immunol. 1991; 21: 2845-50.
49. Upham JW, Strickland DH, Bilyk N, Robinson BWS, Holt PG. Alveolar macrophages from humans and rodents selectively inhibit T cell proliferation but permit T cell activation and cytokine secretion. Immunology 1995; 84: 142-7.
50. Bilyk N, Holt PG. Cytokine modulation of the immunosuppressive phenotype of pulmonary alveolar macrophage populations. Immunology 1995; 86: 231-7.
51. Garcia VE, Iglesias MF, Cerquetti MC, Gomez MI, Sordelli DO. Interaction between granulocytes and antibodies in the enhancement of lung defences against Staphylococcus aureus after intranasal immunization of mice with live-attenuated bacteria. FEMS Immunol. Med. Microbiol. 1994; 9: 55-64.